adacel: Clinical Trials

11 trials of adacel, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

10 completed, 1 terminated. 11 Phase 3, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 311Completed 10, Terminated 1
Phase 22Completed 2

Follow adacel: new trials by email Literature Review of adacel trials Research Report on adacel

Trials (filtered) newest first · largest first

All 11 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Tdap Vaccine Safety for Plasma Donors
Adacel - Tetanus
Phase 2 / Phase 3CompletedGCAM Inc.1102020-02-032022-12-06
Study of a Tetravalent Dengue Vaccine Administered Concomitantly or Sequentially With Adacel® in Healthy Subjects
CYD Dengue Vaccine, Tdap: Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine adsorbed, Tdap: Tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine adsorbed - Dengue Fever, Dengue Hemorrhagic Fever
Phase 3TerminatedSanofi Pasteur, a Sanofi Company6882016-12-192022-03-25
Study of SP306 Given Intramuscularly Compared to DT Given Subcutaneously in Japanese Adolescents 11 - 12 Years Old
Tdap: Tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine adsorbed, Diphtheria and Tetanus toxoids adsorbed - Tetanus, Diphtheria
Phase 3CompletedSanofi Pasteur, a Sanofi Company5342014-03-012017-05-30
Sanofi Pasteur's Tdap Combined Vaccine as a Booster Versus Local DT Vaccine in Children or Versus Local Td Vaccine in Adolescents and Adults in China.
Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine Adsorbed Tdap (ADACEL), DT vaccine (Diphtheria and Tetanus Combined Vaccine, Adsorbed), Td vaccine (Diphtheria and Tetanus Combined Vaccine for Adults and Adolescents, Adsorbed) - Diphtheria, Tetanus
Phase 3CompletedSanofi Pasteur, a Sanofi Company14402013-11-012015-05-19
Safety and Immunogenicity Study for Use of Menactra® Versus Adacel® in Subjects 11 to 55 Years of Age in South Korea
Meningococcal (Groups A, C, Y and W-135) Polysaccharide Diphtheria Toxoid Conjugate Vaccine (Menactra®), Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine Adsorbed - Meningitis, Meningococcal Disease
Phase 3CompletedSanofi Pasteur, a Sanofi Company3002012-07-012013-12-03
A Study to Assess the Safety of Adacel® Vaccine
Adacel® (Tetanus, Reduced Diphtheria Toxoid and Acellular Pertussis) - Diphtheria, Tetanus
Phase 3CompletedSanofi Pasteur, a Sanofi Company302009-12-012016-05-16
Pertussis Maternal Immunization Study
Tdap, Td - Pregnant Women
Phase 2 / Phase 3CompletedScott Halperin3202007-11-012020-08-27
Persistence Study of GSK Biologicals' Tdap Vaccine 1, 3, 5 and 9 Years Following Administration as an Initial Single Dose in Healthy Young Adults and to Evaluate the Immunogenicity and Safety of Boostrix as a Second Dose of Tdap, When Administered at Year 9
Taking of blood samples, Boostrix, Adacel - Acellular Pertussis, Tetanus
Phase 3CompletedGlaxoSmithKline19542007-06-012020-05-01
Safety and Immunogenicity of Tdap Vaccine Compared to DTaP Vaccine in Children 4 to 6 Years of Age
Tdap (Tetanus Toxoid Reduced Diphtheria Toxoid/Acellular Pertussis), DTaP (Diphtheria & Tetanus Toxoids & Acellular Pertussis Adsorbed) - Tetanus, Diphtheria
Phase 3CompletedSanofi Pasteur, a Sanofi Company10452007-04-012014-02-07
Safety and Immunogenicity of GSK's Tdap Vaccine (Boostrix) in Adults Aged 19 to 64 Years
Boostrix™, ADACEL® - Acellular Pertussis, Diphtheria
Phase 3CompletedGlaxoSmithKline23372006-07-132018-08-07
Immunogenicity and Safety of ADACEL™ as Fifth Dose in Taiwan
Diphteria, tetanus, and Acellular Pertussis vaccine - Diphtheria, Tetanus
Phase 3CompletedSanofi Pasteur, a Sanofi Company1152005-11-012016-04-14

Conditions studied

Tetanus (8)  ·  Diphtheria (7)  ·  Whooping Cough (7)  ·  Dengue (1)  ·  Meningitis (1)  ·  Meningococcal Infections (1)  ·  Severe Dengue (1)

Sponsors

Sanofi Pasteur, a Sanofi Company (7)  ·  GlaxoSmithKline (2)  ·  GCAM Inc. (1)  ·  Scott Halperin (1)

Countries

United States (4)  ·  Canada (2)  ·  China (1)  ·  Japan (1)  ·  Philippines (1)  ·  South Korea (1)  ·  Taiwan (1)  ·  Vietnam (1)

Top investigators

Scott A Halperin, MD (1)

Results publications

PMID 21945698, PMID 30010773, PMID 34117198, PMID 38461048

NIH funding

2019 (1)